PieX AI announced today that it launched a pendant featuring on-device AI for managing mental health through sensing technology. The company says it aims for the product to revolutionize mental health management. It seamlessly integrates AI and sensing technology with emotional wellbeing. PieX wants to enhance mental health through advanced applications like AI life coaching, […]
Latest News on MassDevice
Qalo launches health-tracking smart ring
Qalo today unveiled its latest silicone smart ring technology for health tracking, called QRNT (pronounced “current”). The company said its newest offering combines its signature silicone material with advanced health-tracking technology. It aims to introduce a product that empowers users to take small but impactful steps toward better health. QRNT (Qalo ring with nanotechnology) delivers […]
Bioventus divests Advanced Rehabilitation business to PE firm
Bioventus (Nasdaq:BVS) announced today that it successfully completed the divestiture of its Advanced Rehabilitation business. The Durham, North Carolina-based company divested the unit to Accelmed Partners. Accelmed, a private equity (PE) firm, focuses on acquiring and growing commercial-stage healthtech companies. Bioventus initially announced the deal to divest Advanced Rehabilitation on Oct. 1, 2024. The company […]
Navigantis reports first clincial cases with neurovascular surgical robot
Navigantis recently announced the first successful neurovascular clinical cases performed with its Vasco interventional robotic platform. The Miami-based company designed its Vasco platform for patients with neurovascular disorders, including acute ischemic stroke. It conducted first-in-human cases in 2022. In those cases, the platform’s previous generation successfully performed robotic embolization of liver tumors. Navigantis said its […]
The top medtech stories of 2024
AFib-treating cardiac ablation, surgical robotics, nitinol and diabetes treatment tech lead among this year’s top medtech stories. Meanwhile, medical device companies have been seeking more tuck-in M&A — and continuing to refocus and boost operational efficiency — to better prepare for whatever the future brings. Here are the top medtech stories that caught the attention […]
Siemens to reevaluate Siemens Healthineers majority stake
Siemens officials question whether they should keep the company’s majority stake in its former medtech division, Siemens Healthineers (XETRA: SHL.DE). The plan is to evaluate the economic opportunities for Siemens in the healthcare space and then determine how instrumental it is to have Healthineers as an investment, Siemens CFO Ralf Thomas told the Handelsblatt newspaper in […]
Autonomix secures U.S. patent for cancer-treating tech
Autonomix today announced it received a patent from the U.S. Patent and Trademark Office (USPTO) for its catheter-based cancer tumor treating technology. The patent, titled Systems and Methods for Treating Cancer and/or Augmenting Organ Function, covers the company technology, including systems, methods, and devices for interventionally treating cancerous tumors and cancer-related pain. Autonomix plans to […]
The biggest medtech M&A moves of 2024
In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Olympus is looking for a new CEO
Olympus has engaged a global executive recruitment firm to assist a board search committee in evaluating CEO candidates. The Tokyo-based medtech company said in a Dec. 20 news release: “Olympus Corporation is committed to completing the CEO succession process as swiftly and efficiently as possible to ensure continued leadership and growth.” Board chair and former […]
Abbott, Dexcom settle global CGM patent litigation
Abbott and Dexcom, two leaders in the continuous glucose monitor market, today struck a settlement agreement for ongoing patent litigation. Our sibling site, Drug Delivery Business News, reports today that the companies settled all outstanding patent disputes between them. The patent litigation relates to the companies’ continuous glucose monitor (CGM) technologies. The companies and Dexcom […]
Edwards Lifesciences scores a win at CMS for TTVR
The Centers for Medicare & Medicaid Services (CMS) has announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries with severe symptomatic tricuspid regurgitation. The proposed decision would allow coverage under a Coverage with Evidence Development (CED) framework, requiring the procedure to be part of a CMS-approved clinical study to ensure […]
